Diseases, Conditions, Syndromes

US approves dengue vaccine Dengvaxia

US health authorities have given their approval to dengue vaccine Dengvaxia, the controversial first treatment designed to protect against the deadly mosquito-borne virus.

Diseases, Conditions, Syndromes

Scientists develop infection model for tickborne flaviviruses

National Institutes of Health (NIH) scientists have filled a research gap by developing a laboratory model to study ticks that transmit flaviviruses, such as Powassan virus. Powassan virus was implicated in the death of a ...

Diseases, Conditions, Syndromes

Investigating acute hepatitis of unknown origin in children

Since Fall 2021, an increasing number of unexplained cases of severe acute hepatitis have been reported in children. Epidemiologic investigation is ongoing, and, to date, a cause of these outbreaks has not been identified. ...

Diseases, Conditions, Syndromes

Research teams hone in on Zika vaccines, but challenges remain

As public health officials warn that spring's warmer temperatures may herald another increase of Zika virus infections in the Caribbean and North and South America, researchers around the world are racing to develop safe ...

Diseases, Conditions, Syndromes

In Baltimore, lower income neighborhoods have bigger mosquitoes

Low-income urban neighborhoods not only have more mosquitoes, but they are larger-bodied, indicating that they could be more efficient at transmitting diseases. So reports a Cary Institute of Ecosystem Studies-led study, ...

Diseases, Conditions, Syndromes

Modeling identifies mosquito risk hotspots in Germany

Scientists at the Senckenberg Research Center for Biodiversity and Climate and at the Goethe University, in conjunction with other German colleagues, have developed distribution models for the invasive Asian rock pool mosquito. ...

page 18 from 35